Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENTX | AMGN | VRTX | REGN | BMY |
| Company | Entera Bio Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.9300 | 318.72 | 454.98 | 1,015.40 | 53.40 |
| High | 1.9300 | 320.74 | 458.14 | 1,023.09 | 54.01 |
| Low | 1.8110 | 316.43 | 452.62 | 1,007.28 | 53.30 |
| Last | 1.8700 | 319.66 | 455.31 | 1,012.82 | 53.96 |
| Change | +0.0300 | +2.18 | +1.76 | -1.77 | +0.36 |
| % Change | +1.63% | +0.69% | +0.39% | -0.17% | +0.67% |
| Volume | 16,100 | 1,467,800 | 781,700 | 1,071,700 | 12,831,800 |
| 20-Day Average Volume | 36,095 | 2,096,945 | 966,380 | 689,055 | 13,111,021 |
| Previous Close | 1.8400 | 317.48 | 453.55 | 1,014.59 | 53.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9307 | 327.11 | 469.25 | 1,094.59 | 50.49 |
| 20-Day Raw Stochastic | 25.87% | 27.77% | 8.05% | 3.39% | 91.70% |
| 20-Day Relative Strength | 50.35% | 45.19% | 40.75% | 31.95% | 67.65% |
| Weighted Alpha | +57.32 | +18.06 | +21.44 | +16.09 | +4.40 |
| Today's Opinion | 24% Buy | 24% Buy | 8% Buy | 8% Buy | 88% Buy |
| Previous Opinion | 24% Buy | 24% Buy | 8% Buy | 8% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 64% Buy | 40% Buy | 80% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.97% since 09/27/24 | -0.93% since 09/27/24 | -1.64% since 09/27/24 | -2.86% since 09/27/24 | +5.99% since 09/27/24 |
| Low | 1.8100 on 10/03/24 | 315.46 on 10/03/24 | 452.26 on 10/03/24 | 1,007.28 on 10/04/24 | 51.03 on 09/30/24 |
| High | 2.0100 on 09/30/24 | 323.23 on 09/30/24 | 472.31 on 10/01/24 | 1,061.60 on 10/01/24 | 54.54 on 10/02/24 |
| 1-Month | |||||
| %Chg | -0.53% since 09/04/24 | -3.32% since 09/04/24 | -4.86% since 09/04/24 | -14.12% since 09/04/24 | +8.01% since 09/04/24 |
| Low | 1.7605 on 09/12/24 | 312.16 on 09/25/24 | 452.26 on 10/03/24 | 1,007.28 on 10/04/24 | 47.55 on 09/09/24 |
| High | 2.1837 on 09/19/24 | 339.17 on 09/23/24 | 490.15 on 09/16/24 | 1,175.16 on 09/05/24 | 54.54 on 10/02/24 |
| 3-Month | |||||
| %Chg | +14.02% since 07/03/24 | +3.32% since 07/03/24 | -3.18% since 07/03/24 | -1.10% since 07/03/24 | +34.70% since 07/03/24 |
| Low | 1.4100 on 08/05/24 | 306.59 on 08/07/24 | 452.26 on 10/03/24 | 1,007.28 on 10/04/24 | 39.35 on 07/05/24 |
| High | 2.1837 on 09/19/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.54 on 10/02/24 |
| 6-Month | |||||
| %Chg | -1.58% since 04/04/24 | +19.24% since 04/04/24 | +12.70% since 04/04/24 | +8.09% since 04/04/24 | +4.98% since 04/04/24 |
| Low | 1.4100 on 08/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 3.3500 on 04/12/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.54 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 66,918 | 171,476,816 | 117,494,112 | 111,598,568 | 109,382,312 |
| Shares Outstanding, K | 35,785 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -8,890,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 60,000 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 12,201,000,000 |
| Last Quarter Net Income | -2,150,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,680,000,000 |
| 60-Month Beta | 1.57 | 0.61 | 0.40 | 0.12 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 08/09/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 10/31/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.07 | 0.00 | 26.41 | 39.56 |